News

The insulin-like growth factor-1 (IGF-1) receptor is said to be a promising target for treatment of cancer, since the IGF-1 receptor is crucial for the survival and growth

In the course of the study 13 patients were treated at a glaucoma center in Mexico City, under the supervision of Felix Gil Carrasco, an eye surgeon. IOPtima

The decision was made based on the results of an analysis for futility conducted by the independent data monitoring committee. Due to an observed lower mortality than anticipated

Smith & Nephew Endoscopy and John Hayhurst sued Arthrex over three years ago, claiming that Arthrex’s Bio Suture Tak, Peek Suture Tak and Push Lock suture anchors infringed

The patent covers certain uses of satraplatin related to the treatment of a cancer or tumor resistant or refractory to a taxane, including docetaxel (Taxotere) and paclitaxel (Taxol).

The company reported blinded disease-free survival data for those patients that have completed 36 months of follow-up subsequent to randomization in both the treatment and control arms, with

Joint R&D work is beginning with the Bayer subsidiary Icon Genetics on a novel production approach. Antigens are to be produced for the first time in tobacco plants

Gray Hudkins, president and CEO of Langer, said: “With the divestiture of Regal, our contracture management products and services business, we are pleased to complete another step in

The company said that the results revealed clinical improvement, excellent durability and fracture resistance, and high rates of event-free survival (EFS) and freedom from target lesion revascularization (TLR).